Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
German Chancellor Friedrich Merz has articulated his readiness to participate in U.S. President Donald Trump's initiative, the Board of Peace, specifically aiming at resolving issues in Gaza. However, Merz emphasized that the governance model proposed in the current iteration of the plan conflicts with German constitutional principles, rendering ac…
In a significant step toward peace negotiations, Syrian government forces have assumed control of a key prison in northern Syria following the withdrawal of Kurdish-led Syrian Democratic Forces (SDF). This development occurs as a ceasefire deadline approaches, centered around integrating Kurdish autonomous administrations and security forces into t…
UBS raised its price target for GE Aerospace to $374 from $368 following the company’s strong fourth-quarter 2025 results. The firm maintained a Buy rating, emphasizing solid revenue growth and better-than-expected Commercial Engine Services orders. Despite these metrics, GE Aerospace shares dropped due to valuation concerns. UBS projects continued…
Citigroup has started coverage of e.l.f. Beauty with a Buy recommendation, highlighting the company’s anticipated revenue growth exceeding industry peers and improvement in profit margins. Key drivers include market share gains for e.l.f.’s flagship brand, expanded distribution for the rhode brand acquisition, and expected pricing adjustments. Desp…
UBS has sustained its Buy rating and $158 price target on Abbott Laboratories, even as recent quarterly results fell short of growth expectations. The stock, now near its 52-week low, faces investor skepticism about its 2026 organic sales forecast. Still, UBS highlights potential catalysts in Abbott's MedTech division and confidence in continuous g…
Norway's stock market ended the trading session on a positive note with the Oslo OBX index increasing by 0.52%, propelled by gains in key sectors including Healthcare Equipment & Services, Pharma Biotech & Life Sciences, and Utilities. Notable companies such as Nel ASA and Subsea 7 SA posted significant gains, while SalMar ASA and Gjensidige Forsik…
The Tel Aviv 35 Index closed higher on Friday, climbing by 0.34% to a fresh all-time peak. Gains were driven by strong performances in the insurance, technology, and communication sectors with Shapir Engineering Industry and Clal Insurance Enterprises marking notable rises. Despite these advances, some heavyweight stocks such as NICE Ltd and Tower …
UBS has sustained its Buy rating for Life Time Group Holdings Inc, setting a price target of $43 per share. This recommendation follows quarterly financial results that surpassed expectations and robust future guidance. The company is banking on significant revenue and membership growth, as well as planned opening of new large-scale fitness centers…
UBS has amended its target price for Procter & Gamble shares to $170 from $161, sustaining its Buy rating after the company reported a modest earnings per share advantage in its fiscal second quarter. The positive earnings surprise, combined with attractive valuation relative to peers and anticipated organic growth acceleration, has led multiple an…
UBS has raised its price target for CACI International to $787 from $752, reaffirming a Buy rating on the stock after the company's robust fiscal second-quarter results. CACI's focus on software-defined national security solutions amid increased governmental budget allocations and acquisition reforms underpins favorable projections, despite minor i…
UBS has maintained its Buy rating on Diamondback Energy with a price objective near $194, anticipating a positive earnings report for Q4 2025. The firm's confidence is underpinned by Diamondback’s robust profitability, significant revenue growth, and progress in debt reduction, positioning the company well for market fluctuations. Diamondback’s rec…
The US Securities and Exchange Commission (SEC) has petitioned a US court for permission to directly email summonses to Gautam Adani and Sagar Adani in connection with civil allegations of fraud and bribery. This move follows India's refusal to serve the documents through traditional channels. The SEC's civil case is distinct from an ongoing US Dep…
The Athens General Composite experienced a slight downturn at Friday’s close, primarily influenced by declines in the Telecoms, Household, and Basic Resources sectors. Despite this, select stocks such as Lavipharm SA and Ekter posted significant gains, reaching multi-year highs. Commodities trading showed positive movement with gold and oil prices …
The United States has sanctioned nine vessels identified as part of Iran's 'shadow fleet' and eight related firms, aiming to intensify pressure on Tehran following lethal suppression of domestic protests. These ships, along with their owners and operators based in countries including India, Oman, and the UAE, have been integral in transporting subs…
DA Davidson has maintained a Buy rating and a $93 price target on Customers Bancorp shares, following the bank's latest quarterly and annual financial results. Although core earnings per share came just shy of the firm's estimates and revenue lagged expectations in the fourth quarter, robust net interest income growth and ongoing deposit franchise …
DA Davidson has revised its price target for Heritage Financial upwards to $32 from $29, maintaining a Buy rating. The brokerage highlights the bank's improving net interest margin in the fourth quarter of 2025, alongside strong revenue growth and anticipated benefits from an impending acquisition. Heritage Financial's earnings have recently exceed…
UBS has elevated the price target for C.H. Robinson Worldwide to $224 from $177, maintaining a Buy rating due to anticipated productivity improvements from agentic AI deployment, expected strong truckload pricing and volume growth in 2027, and rising earnings forecasts. The logistics firm's share price currently nears its 52-week high amid favorabl…
UBS has adjusted its price target for Microsoft to $600, down from $650, citing a general valuation decline across the software industry. Although the target has been reduced, the firm retains a Buy rating and acknowledges Microsoft's premium positioning relative to its peers. Optimism around Azure's expansion continues, supported by new Fairwater …
DA Davidson continues to recommend a Buy rating on Glacier Bancorp (NYSE:GBCI) with a price target of $55.00, reflecting optimism about the bank’s growth prospects driven by strong quarterly earnings, expansion in net interest margins, and strategic acquisitions. Despite modest organic growth, Glacier Bancorp’s financial stability and dividend cons…
Coherus Oncology's stock experienced a 35% increase after Oppenheimer commenced coverage with an Outperform rating and a $10 target price, indicating over 500% potential upside from the previous close. The firm cited the company's promising clinical pipeline and strategic advantage with an approved PD-1 inhibitor backbone as factors for expected gr…
Tesla has begun operating fully autonomous vehicles without safety drivers in its Austin robotaxi pilot, marking a significant step in its autonomous driving capabilities. Morgan Stanley views this advancement as a pivotal validation of Tesla’s camera-based autonomy system and anticipates rapid expansion of robotaxi services across multiple U.S. me…
DA Davidson has revised its price target for Broadridge Financial (NYSE:BR) downward to $228 from $240, maintaining a Neutral stance despite a stronger recent quarterly performance by the company. The adjustment reflects broader market valuation pressures observed across peer firms and slight reductions in second-quarter revenue and earnings projec…
Litchfield Hills Research initiated coverage of cybersecurity firm Cycurion (NASDAQ:CYCU) with a Buy rating and a price target of $7. The firm emphasized the company's solid $80 million contracted backlog, which is roughly four times its projected fiscal year 2024 revenue of $15.67 million, indicating significant growth opportunities. Cycurion is t…
DA Davidson has upgraded its price target on Equity Bancshares to $52 from $50 while keeping a Neutral recommendation. The bank's fourth-quarter 2025 core EPS missed the firm's forecast but exceeded consensus, reflecting strong operating earnings despite a delayed acquisition completion and loan payoff pressures. Credit quality improvements and an …
DA Davidson has lowered its price target for healthcare technology company Phreesia Inc. to $30 from $35, continuing to endorse a Buy rating. This assessment follows a discussion with Phreesia’s CFO regarding growth prospects, although recent stock price declines highlight investor concerns. The revised target price implies substantial upside relat…
